147 related articles for article (PubMed ID: 37993744)
21. ASO Author Reflections: Laparoscopic Surgery of Perihilar Cholangiocarcinoma Between Oncologic Adequacy and Technical Challenges.
Ratti F; Aldrighetti L
Ann Surg Oncol; 2020 Dec; 27(13):5193-5194. PubMed ID: 32458328
[No Abstract] [Full Text] [Related]
22. ASO Author Reflections: Total Three-Dimensional Guided Laparoscopic Radical Resection for Perihilar Cholangiocarcinoma-Transitioning from the Plane to the Realm of Dimensionality.
Ma WJ; Zhou RX; Jin YW; Li FY
Ann Surg Oncol; 2024 May; 31(5):3102-3103. PubMed ID: 38261124
[No Abstract] [Full Text] [Related]
23. ASO Author Reflections: Chasing a Microscopic Cancer-Free Margin During Resection for Perihilar Cholangiocarcinoma: Can Additional Resection Improve the Long-Term Outcomes?
Kawano F; Ito H; Takahashi Y
Ann Surg Oncol; 2023 Jun; 30(6):3360-3361. PubMed ID: 36749503
[No Abstract] [Full Text] [Related]
24. ASO Author Reflections: Left Trisectionectomy for Bismuth-Corlette Type IV Perihilar Cholangiocarcinoma with Left-Sided Predominance.
Hosokawa I; Shimizu H
Ann Surg Oncol; 2020 Jul; 27(7):2387-2388. PubMed ID: 32323086
[No Abstract] [Full Text] [Related]
25. ASO Author Reflections: Essential to Reduce Adverse Outcomes in Perihilar Cholangiocarcinoma Surgery-Portal Vein Embolization.
Olthof PB; van Gulik TM
Ann Surg Oncol; 2020 Jul; 27(7):2319-2320. PubMed ID: 32152772
[No Abstract] [Full Text] [Related]
26. ASO Author Reflections: Clinical Outcomes of Robotic Resection for Perihilar Cholangiocarcinoma: A First Multicenter, Trans-Atlantic, Expert-Center Collaborative Study.
Sucandy I; Marques HP; Lippert T; Magistri P; Coelho JS; Ross SB; Chumbinho B; Di Sandro S; DiBenedetto F
Ann Surg Oncol; 2024 Jan; 31(1):154-155. PubMed ID: 37773564
[No Abstract] [Full Text] [Related]
27. ASO Author Reflections: Incorporating Circulating Tumor DNA in Perioperative Management of Intrahepatic Cholangiocarcinoma.
Choi WJ; Sapisochin G; O'Kane GM
Ann Surg Oncol; 2023 Jun; 30(6):3864-3865. PubMed ID: 36752965
[No Abstract] [Full Text] [Related]
28. ASO Author Reflections: Intrahepatic Cholangiocarcinoma: Downstaging Strategies Open the Gate to Surgery and Cure.
Boudjema K; Edeline J
Ann Surg Oncol; 2020 Oct; 27(10):3738-3739. PubMed ID: 32314152
[No Abstract] [Full Text] [Related]
29. ASO Author Reflections: Disparate Outcomes in Stage II Intrahepatic Cholangiocarcinoma: A Case for Upstaging Multifocal Tumors.
Turner KM; Wilson GC
Ann Surg Oncol; 2022 Aug; 29(8):5103-5104. PubMed ID: 35482267
[No Abstract] [Full Text] [Related]
30. ASO Author Reflections: Lymph Node Examination and Patterns of Nodal Metastasis of Left- Versus Right-Sided Intrahepatic Cholangiocarcinoma.
Zhang XF; Pawlik TM
Ann Surg Oncol; 2023 Mar; 30(3):1434-1435. PubMed ID: 36380253
[No Abstract] [Full Text] [Related]
31. ASO Author Reflections: Use of Machine Learning to Predict Early Recurrence After Resection of Intrahepatic Cholangiocarcinoma.
Alaimo L; Pawlik TM
Ann Surg Oncol; 2023 Sep; 30(9):5416-5417. PubMed ID: 37222944
[No Abstract] [Full Text] [Related]
32. ASO Author Reflections: Accuracy of Preoperative Staging and Downstaging After Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma.
Alaimo L; Lima HA; Moazzam Z; Pawlik TM
Ann Surg Oncol; 2023 Aug; 30(8):4809-4810. PubMed ID: 37046130
[No Abstract] [Full Text] [Related]
33. ASO Author Reflections: Higher Tumor Burden Status Dictates the Impact of Surgical Margin Status in Patients with Intrahepatic Cholangiocarcinoma.
Endo Y; Moazzam Z; Lima HA; Pawlik TM
Ann Surg Oncol; 2023 Apr; 30(4):2033-2034. PubMed ID: 36396871
[No Abstract] [Full Text] [Related]
34. ASO Author Reflections: Identification of Intrahepatic Cholangiocarcinoma Clusters Using Machine Learning Techniques: Should Patients be Treated Differently?
Tsilimigras DI; Paredes AZ; Pawlik TM
Ann Surg Oncol; 2020 Dec; 27(13):5233-5234. PubMed ID: 32591955
[No Abstract] [Full Text] [Related]
35. ASO Author Reflections: A New Reliable Method of Evaluating Cancer-Associated Fibroblasts in Resected Specimen of Intrahepatic Cholangiocarcinoma.
Eguchi S; Yamada D; Kobayashi S; Sasaki K; Iwagami Y; Tomimaru Y; Noda T; Takahashi H; Asaoka T; Tanemura M; Doki Y; Eguchi H
Ann Surg Oncol; 2023 Sep; 30(9):5429-5430. PubMed ID: 37273026
[No Abstract] [Full Text] [Related]
36. Liver Transection-First Approach in Left Trisectionectomy for Perihilar Cholangiocarcinoma.
Hosokawa I; Shimizu H; Ohtsuka M; Miyazaki M
Ann Surg Oncol; 2020 Jul; 27(7):2381-2386. PubMed ID: 32152773
[TBL] [Abstract][Full Text] [Related]
37. Additional stenting for hilar cholangiocarcinoma using a novel delivery device after uncovered metallic stent placements.
Yasuda M; Matsumori T; Uza N; Shiokawa M; Maruno T; Okada H; Seno H
Endoscopy; 2023 Dec; 55(S 01):E521-E522. PubMed ID: 36894149
[No Abstract] [Full Text] [Related]
38. ASO Author Reflections: Long-Term Outcomes and Optimal Margin Width Among Patients Undergoing Hepatectomy for Intrahepatic Cholangiocarcinoma.
Alaimo L; Moazzam Z; Pawlik TM
Ann Surg Oncol; 2023 Jul; 30(7):4302-4303. PubMed ID: 36964330
[No Abstract] [Full Text] [Related]
39. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
[TBL] [Abstract][Full Text] [Related]
40. ASO Author Reflections: Monitoring the Risk of Recurrence After Curative-Intent Liver Resection for Intrahepatic Cholangiocarcinoma by Applying Hazard Function Analysis.
Alaimo L; Moazzam Z; Pawlik TM
Ann Surg Oncol; 2023 Mar; 30(3):1350-1351. PubMed ID: 36006495
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
